Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.
J Clin Oncol. 2020 Mar 10;38(8):784-792. doi: 10.1200/JCO.19.01231. Epub 2019 Nov 26.
J Clin Oncol. 2020.
PMID: 31770060